Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Springer

Showing results (221-230 of 280) with videos related to

Pageof 28
Sort By:
Cancer|February 1, 1994
Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapyS K Sharma, K D Bagshawe, P J Burke, et al.
Transplantation Proceedings|April 1, 1990
Evolution of the Colorado Organ Recovery SystemsE K Spees, J P Orlowski, J Springer, et al.
The American Journal of Cardiology|July 15, 1990
Benefits of physiologic atrioventricular synchronization for pacing with an exercise rate responseJ S Landzberg, J O Franklin, S K Mahawar, et al.
Journal of the American College of Cardiology|November 1, 1990
Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junctionM Rosenquvist, M A Lee, L Moulinier, et al.
Plos One|June 12, 2010
Extracellular fibrils of pathogenic yeast Cryptococcus gattii are important for ecological niche, murine virulence and human neutrophil interactionsDeborah J Springer, Ping Ren, Ramesh Raina, et al.
Cancer Research|June 17, 2005
Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2Silke Schepelmann, Paul Hallenbeck, Lesley M Ogilvie, et al.
Annals of Family Medicine|June 28, 2021
Improving Smoking and Blood Pressure Outcomes: The Interplay Between Operational Changes and Local ContextDeborah J Cohen, Shannon M Sweeney, William L Miller, et al.
Cancer Research|March 26, 2002
Three new prodrugs for suicide gene therapy using carboxypeptidase G2 elicit bystander efficacy in two xenograft modelsFrank Friedlos, Lawrence Davies, Ian Scanlon, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase geneP F Searle, S J Weedon, I A McNeish, et al.
Disease Markers|May 1, 1991
Antibody directed enzyme prodrug therapy (ADEPT): clinical reportK D Bagshawe, S K Sharma, C J Springer, et al.
Pageof 28

Showing results (221-230 of 280) with videos related to

Sort By:
Pageof 28
Cancer|February 1, 1994
Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapyS K Sharma, K D Bagshawe, P J Burke, et al.
Transplantation Proceedings|April 1, 1990
Evolution of the Colorado Organ Recovery SystemsE K Spees, J P Orlowski, J Springer, et al.
The American Journal of Cardiology|July 15, 1990
Benefits of physiologic atrioventricular synchronization for pacing with an exercise rate responseJ S Landzberg, J O Franklin, S K Mahawar, et al.
Journal of the American College of Cardiology|November 1, 1990
Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junctionM Rosenquvist, M A Lee, L Moulinier, et al.
Plos One|June 12, 2010
Extracellular fibrils of pathogenic yeast Cryptococcus gattii are important for ecological niche, murine virulence and human neutrophil interactionsDeborah J Springer, Ping Ren, Ramesh Raina, et al.
Cancer Research|June 17, 2005
Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2Silke Schepelmann, Paul Hallenbeck, Lesley M Ogilvie, et al.
Annals of Family Medicine|June 28, 2021
Improving Smoking and Blood Pressure Outcomes: The Interplay Between Operational Changes and Local ContextDeborah J Cohen, Shannon M Sweeney, William L Miller, et al.
Cancer Research|March 26, 2002
Three new prodrugs for suicide gene therapy using carboxypeptidase G2 elicit bystander efficacy in two xenograft modelsFrank Friedlos, Lawrence Davies, Ian Scanlon, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase geneP F Searle, S J Weedon, I A McNeish, et al.
Disease Markers|May 1, 1991
Antibody directed enzyme prodrug therapy (ADEPT): clinical reportK D Bagshawe, S K Sharma, C J Springer, et al.
Pageof 28